Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol for PF-05280602, including a change in the revision number from v2.14.4 to v2.15.0, and the removal of detailed study hypotheses and criteria for participation.SummaryDifference9%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.